Congenital disorders of glycosylation (CDG): state of the art in 2022 [PDF]
Orphanet Journal of Rare Diseases, 2023 Congenital disorders of glycosylation (CDG) are a complex and heterogeneous family of rare metabolic diseases. With a clinical history that dates back over 40 years, it was the recent multi-omics advances that mainly contributed to the fast-paced and ...
Rita Francisco +6 more
doaj +5 more sources
Nutritional Therapies in Congenital Disorders of Glycosylation (CDG). [PDF]
Nutrients, 2017 Congenital disorders of glycosylation (CDG) are a group of more than 130 inborn errors of metabolism affecting N-linked, O-linked protein and lipid-linked glycosylation. The phenotype in CDG patients includes frequent liver involvement, especially the disorders belonging to the N-linked protein glycosylation group.
Witters P, Cassiman D, Morava E.
europepmc +4 more sources
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG). [PDF]
Int J Mol Sci, 2022 Advances in research have boosted therapy development for congenital disorders of glycosylation (CDG), a group of rare genetic disorders affecting protein and lipid glycosylation and glycosylphosphatidylinositol anchor biosynthesis. The (re)use of known drugs for novel medical purposes, known as drug repositioning, is growing for both common and rare ...
Brasil S +14 more
europepmc +7 more sources
Zebrafish models for congenital disorders of glycosylation (CDG): a systematic review [PDF]
Orphanet Journal of Rare DiseasesGlycosylation is a post-translational modification of proteins that involves the addition of glycan groups and is essential for their proper functionality. This highly complex process affects 70% of all human proteins.
N. Gandoy-Fieiras +2 more
doaj +2 more sources
Genetic counseling for congenital disorders of glycosylation (CDG). [PDF]
J Genet CounsAbstractCongenital disorders of glycosylation (CDGs) are a genetically and clinically diverse group of disorders that arise as a result of defects within glycosylation synthetic pathways. CDGs are caused by pathogenic variants in many different genes in the glycosylation network.
Weixel T, Wolfe L, Macnamara EF.
europepmc +3 more sources
Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update. [PDF]
Genet Med, 2020 Congenital disorders of glycosylation (CDG) are a group of clinically and genetically heterogeneous metabolic disorders. Over 150 CDG types have been described. Most CDG types are ultrarare disorders. CDG types affecting N-glycosylation are the most common type of CDG with emerging therapeutic possibilities.
Verheijen J +4 more
europepmc +5 more sources
Putative role of TMEM165 in congenital cardiomyopathies [PDF]
Frontiers in Molecular NeuroscienceWithin the significant worldwide causes of mortality and morbidity are congenital heart diseases. Congenital cardiomyopathies include conditions in which early diagnosis and care can improve survival and health.
Paula P. Gonçalves
doaj +2 more sources
Clinical and genetic characterization of congenital disorders of glycosylation in 20 Chinese patients [PDF]
Orphanet Journal of Rare DiseasesBackground Congenital disorders of glycosylation (CDG) are a complex and heterogeneous family of rare metabolic diseases that affect protein and lipid glycosylation and glycosylphosphatidylinositol synthesis.
Peiwei Zhao +8 more
doaj +2 more sources
Insights into ALG3-CDG: A case study combining glycan profiling and genetic analysis [PDF]
Molecular Genetics and Metabolism ReportsCongenital disorders of glycosylation (CDG) are a group of rare metabolic disorders caused by the defects in the glycosylation pathways of biomacromolecules leading to altered glycoprofiles in affected individuals. In this case study, we present a 3-year-
Rebeka Kodríková +8 more
doaj +2 more sources
Are viral vector-mediated therapies compatible with aberrant glycosylation? [PDF]
Molecular Therapy: Methods & Clinical DevelopmentThe ability of adeno-associated viruses (AAVs) to transduce host cells relies on interactions with glycan moieties on the cellular surface.
I.J.J. Muffels +6 more
doaj +2 more sources